Evidence map›Paper›PMID 27219062›Full record

ArticleDevelopmental cell2016

The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis.

Megan L Goodall, Brent E Fitzwalter, Shadi Zahedi, Min Wu, Diego Rodriguez, Jean M Mulcahy-Levy, Douglas R Green, Michael Morgan, Scott D Cramer, Andrew Thorburn

Open access · greenAbstract read
In one paragraph

Article in Developmental cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 207 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
207citing papers in PubMed, 3 pooled it
24.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

207 citing papers in PubMed, 3 syntheses or guidelines pooled it, 300 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Mechanisms, regulation and clinical relevance of necroptosis.Nature reviews. Molecular cell biology · 2026
    Review
  6. Review
  7. Autophagy modulation in cancer.Nature reviews. Drug discovery · 2026
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

147 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Megan L GoodallDepartment of Pharmacology, University of Colorado Denver, Aurora, CO 80045, USA.
Brent E FitzwalterDepartment of Pharmacology, University of Colorado Denver, Aurora, CO 80045, USA.
Shadi ZahediDepartment of Pediatrics, University of Colorado Denver, Aurora, CO 80045, USA.
Min WuDepartment of Pharmacology, University of Colorado Denver, Aurora, CO 80045, USA; Department of Molecular and Cellular Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Diego RodriguezDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Jean M Mulcahy-LevyDepartment of Pediatrics, University of Colorado Denver, Aurora, CO 80045, USA.
Douglas R GreenDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Michael MorganDepartment of Pharmacology, University of Colorado Denver, Aurora, CO 80045, USA.
Scott D CramerDepartment of Pharmacology, University of Colorado Denver, Aurora, CO 80045, USA.
Andrew ThorburnDepartment of Pharmacology, University of Colorado Denver, Aurora, CO 80045, USA. Electronic address: andrew.thorburn@ucdenver.edu.
University of Colorado Denver · USSt. Jude Children's Research Hospital · USThe University of Texas MD Anderson Cancer Center · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Non-canonical functions of autophagy proteinsR01AI040646 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GREEN, DOUGLAS R. · 1997 to 2023
$8.6M
PREDOCTORAL TRAINING PROGRAM IN PHARMACOLOGYT32GM007635 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI DELL'ACQUA, MARK L · 1985 to 2023
$6.1M
Role of autophagy in tumor cell deathR01CA150925 · NCI · UNIVERSITY OF COLORADO DENVER · PI DEGREGORI, JAMES V · 2010 to 2024
$5.5M
BCL2 Family Protein Interactions In Cellular Survival StatesR01GM096208 · NIGMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GREEN, DOUGLAS R. · 2011 to 2018
$2.7M
Therapeutic targeting of autophagy-dependent cancerR01CA190170 · NCI · UNIVERSITY OF COLORADO DENVER · PI GUSTAFSON, DANIEL L, THORBURN, ANDREW M · 2015 to 2019
$2.5M
CHD1 and MAP3K7 coordinate deletion in aggressive ERG translocation negative prostate cancerR01CA199741 · NCI · UNIVERSITY OF COLORADO DENVER · PI CRAMER, SCOTT D · 2015 to 2019
$1.8M
The Interaction of Autophagy and BRAF Mutations in Brain TumorsK08CA193982 · NCI · UNIVERSITY OF COLORADO DENVER · PI MULCAHY LEVY, JEAN MARIE · 2015 to 2019
$822k
Autophagy regulation of prostate tumor developmentR21CA197887 · NCI · UNIVERSITY OF COLORADO DENVER · PI CRAMER, SCOTT D, THORBURN, ANDREW M · 2016 to 2017
$372k
CHD1 and TAK1 Synthetic Lethality in Prostate CancerR21CA187354 · NCI · UNIVERSITY OF COLORADO DENVER · PI CRAMER, SCOTT D · 2015 to 2016
$372k
Investigating the role of autophagy in Tak1 null prostate cancer and TRAIL sensitivityF32CA196080 · NCI · UNIVERSITY OF COLORADO DENVER · PI GOODALL, MEGAN L · 2016 to 2018
$124k
NCI NIH HHS F32 CA196080NCI NIH HHS K08 CA193982NCI NIH HHS P30 CA046934NCI NIH HHS R01 CA150925NCI NIH HHS R01 CA190170NCI NIH HHS R01 CA199741NCI NIH HHS R21 CA187354NCI NIH HHS R21 CA197887NIAID NIH HHS R01 AI040646NIGMS NIH HHS R01 GM096208NIGMS NIH HHS T32 GM007635
6 · The paper itself

Abstract

Although autophagy controls cell death and survival, underlying mechanisms are poorly understood, and it is unknown whether autophagy affects only whether or not cells die or also controls other aspects of programmed cell death. MAP3K7 is a tumor suppressor gene associated with poor disease-free survival in prostate cancer. Here, we report that Map3k7 deletion in mouse prostate cells sensitizes to cell death by TRAIL (TNF-related apoptosis-inducing ligand). Surprisingly, this death occurs primarily through necroptosis, not apoptosis, due to assembly of the necrosome in association with the autophagy machinery, mediated by p62/SQSTM1 recruitment of RIPK1. The mechanism of cell death switches to apoptosis if p62-dependent recruitment of the necrosome to the autophagy machinery is blocked. These data show that the autophagy machinery can control the mechanism of programmed cell death by serving as a scaffold rather than by degrading cargo.

Indexed as

ApoptosisAutophagyAnimalsAutophagosomesAutophagy-Related Protein 5Epithelial CellsHumansMaleMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesMiceNecrosisProstatic NeoplasmsReceptor-Interacting Protein Serine-Threonine KinasesReceptors, Death DomainRNA-Binding ProteinsAtg5 protein, mouseAutophagy-Related Protein 5MAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesP62 protein, humanReceptor-Interacting Protein Serine-Threonine KinasesReceptors, Death DomainRipk1 protein, mouseRNA-Binding ProteinsTNF-Related Apoptosis-Inducing Ligand

Identifiers

PMID27219062
PMCPMC4886731
OpenAlexW2402677148

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.